Long-Term Results of the RAPCO Trials
Author(s) -
Brian F. Buxton,
Philip Hayward,
Jai Raman,
Simon C. Moten,
Alexander Rosalion,
Ian Gordon,
Siven Seevanayagam,
George Matalanis,
Umberto Benedetto,
Mario Gaudino,
David L. Hare,
Jullien Gaer,
Justin Negri,
Masashi Komeda,
Rinaldo Bellomo,
Laurie Doolan,
Larry McNicol,
John Brennan,
Robert Chan,
David Clark,
Ronald Dick,
Anthony Dortimer,
David Ecclestone,
Omar Farouque,
Dharsh Fernando,
Mark Horrigan,
Anthony Jackson,
Leslie E. Oliver,
Nilesh Mehta,
Voltaire Nadurata,
Nim Nadarajah,
G. Proimos,
Michael Rowe,
Ben Sia,
Christopher D. Webb,
Nagesh Anaveker,
Peter Barlis,
Paul Calafiore,
Boniface Chan,
John Cotroneo,
Jennifer Johns,
E. Jones,
P. Kertes,
David O’Donnell,
Stephen Sylviris,
A. M. TONKIN,
Robert Fabini,
Robert E. Kearney,
Ruth Lim,
M Molan,
Gerard Smith,
Chris Wellman,
John Eng,
Irbaz Hameed,
Margaret Shaw,
S. Gerbo
Publication year - 2020
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.119.045427
Subject(s) - medicine , hazard ratio , radial artery , diabetes mellitus , surgery , internal thoracic artery , heart failure , randomized controlled trial , artery , coronary artery bypass surgery , cardiology , clinical endpoint , confidence interval , bypass grafting , endocrinology
An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best second conduit. The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with that of the right internal thoracic artery (RITA) and the saphenous vein (SV).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom